Well, it is April 12th. I sent my federal income taxes out yesterday. Now it is time to start looking forward to my next tranche. First, here is the current tranche:
Start | Current | Dividend | Pct Gain | R3K Gain | |
AVG | $19.57 | $21.88 | $0.00 | 11.8% | 14.1% |
CA | $29.54 | $31.55 | $1.00 | 10.2% | 14.1% |
$22.79 | $28.04 | $0.57 | 25.6% | 14.1% | |
NSR | $25.82 | 27.82 | $0.00 | 7.8% | 14.1% |
$28.78 | $27.41 | $0.94 | -1.5% | 14.1% | |
Totals | 10.8% | 14.1% |
It is interesting that RCII is my anvil. That was a stock that I felt a month afterwards should not have been on my list. That being said, it was also a stock that started off pretty well and has only recently hit hard times. In January it was over $34. As I have noted several times, NSR has made a remarkable recovery.
My May tranche so far has been my laggard. After two tranches,
- August was up 61%
- November was up 64%
- February was up 93% while
- May is up 47%.
I will probably add a little $ to May, just to bring it closer in size to the other three. I track those adds in my annualized internal rate of return.
I certainly do not have any "locks" to be picked. But here are some leaders:
- HPQ - My work has shown that larger cap stocks paying dividends have tended to do better on the screen. HPQ is both with a 1.8% yield. Also, they are splitting into two companies in 2015 and I believe that may be a catalyst.
- MNDO - I owned this small Israeli company for a short stretch (and a nice gain) earlier this year. They pay a very nice annual dividend and their price has dropped of late.
- ACHI - this is a riskier pick that could really explode upwards. They are in the process of re-stating financials, which has placed them in the penalty box. One downside is they are very lightly traded (of course so was NHTC).
- GILD - large pharmaceutical. There is some concern about competition for their hepatitis drug. I am not a medical expert, but I have noticed when pharmas come on this screen, they tend to do very well (QCOR, FRX, WRCX, VPHM, CBST and ENDP to name a few).
- PFMT, LQDT or TZOO - my studies have shown when a stock is down by more than 30% from a year ago and still on the screen it tends to do well. PFMT is down 60% and LQDT and TZOO are each off 45%. Actually WTW also falls in this category, but I cannot bring myself to buy them.
- PERI - another small Israeli company that is very very cheap and does not show up on screen. I know they have had to adjust to some changes by Google that impacted their revenues. But it is likely priced in.
- CTCM - the Russian TV station. If tensions thaw a bit between the West and Russia, this stock could be a potential double. Might be worth the gamble. Of course you are tied a bit to the Russian economy, which has to be hurting with fall in oil.
- NLNK - do not know much about this company, new to MFI screen. But "genetics" is a buzz word at least worth exploring.
- UIS - I bought them in February and they are pretty much unchanged. A stock that has uneven earnings. You want to buy them after they get hammered with poor earnings. They may get hurt by strong dollar.
- GORO - I always think about them, yet never buy. Gold miner that is cheap. If dollar falls in next year could be a deal.
- RPXC - I have owned a couple times with limited success. Still cheap.
- SJT or CRT - direct exposure to a bet on rising oil prices.
- CBI or AGX - my construction firms I bought last year a now even cheaper.
So a lot of names on the list. Oh, also ENTA should be in the mix. I currently own as a trade.
No comments:
Post a Comment